About Octapharma

Octapharma USA is a subsidiary of Octapharma AG, a global human protein products manufacturer. The company is dedicated to the research and manufacture of human proteins and has been committed to patient care and medical innovation for more than 30 years. Its core business is the development, production, and sale of human proteins from human plasma and human cell-lines. Patients are treated with Octapharma products in the therapeutic areas of hematology, immunotherapy, and critical care. Octapharma USA is headquartered in Paramus, N.J. Octapharma operates three state-of-the-art production sites licensed by the U.S. Food and Drug Administration (FDA), providing a high level of production flexibility.

For more information, please visit www.octapharmausa.com.

View Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome


Call: (201) 604-1130

Email: usmedicalaffairs@octapharma.com

  • Hidden
  • This field is for validation purposes and should be left unchanged.